Evidence map›Paper›PMID 21298009›Full record

ArticlePloS one2011

The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter.

Jufang Shan, Jonathan A Javitch, Lei Shi, Harel Weinstein

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Glycine Transporter 2: Mechanism and Allosteric Modulation.Frontiers in molecular biosciences · 2021
    Review
  15. Review
  16. VGLUT substrates and inhibitors: A computational viewpoint.Biochimica et biophysica acta. Biomembranes · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jufang ShanDepartment of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York, United States of America.
Jonathan A Javitch
Lei Shi
Harel Weinstein
Cornell University · USNew York State Psychiatric Institute

Funding

STRUCTURE/FUNCTION OF THE HUMAN DOPAMINE TRANSPORTERP01DA012408 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI WEINSTEIN, HAREL · 1999 to 2015
$14.2M
Molecular mechanisms of bacterial homologs of neurotransmitter:sodium symportersR01DA017293 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JAVITCH, JONATHAN A · 2003 to 2013
$4.9M
Molecular Determinants for the Action of PsychostimulantsK05DA022413 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JAVITCH, JONATHAN A · 2007 to 2016
$1.3M
The Neurotransmitter: Sodium Symporter Permeation PathwayR00DA023694 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHI, LEI · 2010 to 2012
$725k
The Neurotransmitter: Sodium Symporter Permeation PathwayK99DA023694 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHI, LEI · 2008 to 2009
$180k
NIDA NIH HHS DA012408NIDA NIH HHS DA022413NIDA NIH HHS DA023694NIDA NIH HHS DA17293NIDA NIH HHS K05 DA022413NIDA NIH HHS K99 DA023694NIDA NIH HHS P01 DA012408NIDA NIH HHS R00 DA023694NIDA NIH HHS R01 DA017293
6 · The paper itself

Abstract

backgroundThe dopamine transporter (DAT), a member of the neurotransmitter:Na(+) symporter (NSS) family, terminates dopaminergic neurotransmission and is a major molecular target for psychostimulants such as cocaine and amphetamine, and for the treatment of attention deficit disorder and depression. The crystal structures of the prokaryotic NSS homolog of DAT, the leucine transporter LeuT, have provided critical structural insights about the occluded and outward-facing conformations visited during the substrate transport, but only limited clues regarding mechanism. To understand the transport mechanism in DAT we have used a homology model based on the LeuT structure in a computational protocol validated previously for LeuT, in which steered molecular dynamics (SMD) simulations guide the substrate along a pathway leading from the extracellular end to the intracellular (cytoplasmic) end. METHODOLOGY/PRINCIPAL

findingsKey findings are (1) a second substrate binding site in the extracellular vestibule, and (2) models of the conformational states identified as occluded, doubly occupied, and inward-facing. The transition between these states involve a spatially ordered sequence of interactions between the two substrate-binding sites, followed by rearrangements in structural elements located between the primary binding site and the cytoplasmic end. These rearrangements are facilitated by identified conserved hinge regions and a reorganization of interaction networks that had been identified as gates. CONCLUSIONS/SIGNIFICANCE: Computational simulations supported by information available from experiments in DAT and other NSS transporters have produced a detailed mechanistic proposal for the dynamic changes associated with substrate transport in DAT. This allosteric mechanism is triggered by the binding of substrate in the S2 site in the presence of the substrate in the S1 site. Specific structural elements involved in this mechanism, and their roles in the conformational transitions illuminated here describe, a specific substrate-driven allosteric mechanism that is directly amenable to experiment as shown previously for LeuT.

Indexed as

Allosteric RegulationMolecular Dynamics SimulationBinding SitesDopamine Plasma Membrane Transport ProteinsModels, MolecularProtein BindingProtein ConformationSubstrate SpecificityDopamine Plasma Membrane Transport Proteins

Identifiers

PMID21298009
PMCPMC3029329
OpenAlexW1968537901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.